Jacobs Journal of Psychiatry and Behavioural Science

Is there a Relationship between Poor Iron Status and The Severity of Depression? A Study carried out on Turkish Women Living in Germany

*Vahdet Gul
Department Of Psychiatry And Behavioral Sciences, Erzincan University, ERZINCAN, Turkey

*Corresponding Author:
Vahdet Gul
Department Of Psychiatry And Behavioral Sciences, Erzincan University, ERZINCAN, Turkey
Email:vgul@erzincan.edu.tr

Published on: 2015-12-18

Abstract

Background: It is widely accepted that many factors including medical comorbidity can influence the development of depression in women. There is no evidence, however, that specific medical diagnoses are independent markers for severity of depression.

Objective: This study aims to investigate the iron status of Turkish female patients with depression, to find out if the iron deficiency (ID) is a risk factor in depression. In addition, it also aims to investigate a possible relationship between reduced iron capacity and intensity of the disease.

Method: A retrospective chart review comparison study was carried out to investigate the iron status of Turkish women with a diagnosis of depression, aged between 18 to 43 years old, living in Germany. The iron parameters were measured in the blood of 180 Turkish women with depression, and of 102 Turkish women without depression. The depressed patients were further sub grouped as mild (n=28), moderate (n=74) and severe depression (n=78) by using Hamilton Depression Rating Scale D (HRS). The measurements for red blood cells (RBC), haemoglobin, free iron and ferritin of the participants in the Community Outpatient Clinic were recorded, and the data was statistically analysed. Patients with a family history of a blood disorder except iron deficiency anaemia, patients with increased acute phase reactants, and those who were pregnant, or suffering from malignancies, diabetes mellitus, and/or mental disorders except depression were excluded from this study. Results: We have found a significant negative correlation between ID and the severity of depression. Levels of reduce hemoglobin in peripheral blood, along with iron and ferritin and RBC were found in several of the patients suffering from severe depression.

Conclusion: These findings have been presented with consideration of their clinical implications of ID and depression with a view to conducting further research

Keywords

Depression; Iron Deficiency; Turkish Women

Copyright: © 2015 Vahdet

Introduction

Iron is a major player in multiple processes in the body and is needed for the function of various enzymes and coenzymes including cytochrome C, catalase, and aromatic amino acid hydroxylases [1-3]. Iron provides the delivery of oxygen through hemoglobin to the body tissues. In addition, iron is also found in myoglobin and other iron enzymes that are required to use oxygen for the production of cellular energy. Iron balance is dependent on the body’s iron stores, absorption, and losses. Approximately, two-thirds of body iron is found mainly in the functional part of hemoglobin in the red blood cells. Most of the remaining is storage iron, mainly serum ferritin to be utilized when needed [4-7].

It is estimated that one-third of the world’s population is anemic, the majority being due to iron deficiency (ID). Iron plays an important role in the oxygenation of brain tissue and the synthesis of many neurotransmitters and enzymes of the nervous system. The iron-related enzymes are quite sensitive to depletion of iron throughout the body. In particular, hydroxylases, which are needed for the synthesis of dopamine and serotonin, can malfunction with minor ID before any manifestation of anemia [8-10].

Iron deficiency anemia (IDA) is diagnosed when the hemoglobin concentration is lower than the level considered to be normal for the person’s age, gender, and physiological status, resulting in the reduced capacity of the red blood cells to deliver oxygen to body cells and tissues. Common clinical symptoms include, such as pale conjunctiva, shortness of breath, dizziness, and lethargy [11,12]. The main risk factors for iron deficiency anemia include low intake of iron, poor absorption of iron from diets, chronic loss of iron (i.e. ulcer, metrorrhagia) and some specific periods of life when iron requirements are especially high, such as growth and pregnancy [13,14].

Free iron is toxic to cells as it acts as a catalyst in the formation of free radicals from reactive oxygen species in the process of oxidative stress and neuro-progression [15-18]. Ferritin serves to store iron in a non-toxic form, to deposit it in a safe form, and to transport it to areas where it is required. If the ferritin level is low, there is a risk for lack of iron, which could lead to anemia. Low serum ferritin is the most specific lab test for iron deficiency anemia [19-21]. However, it is less sensitive, since its levels are increased in the blood by any type of acute or chronic inflammation [22-24], and these conditions may convert what would otherwise be a low level of ferritin from lack of iron, into a value in the normal range. For this reason, low ferritin levels carry more information than those in the normal range. A lower-than-normal level may be due to heavy menstrual bleeding, vegetarianism, intestinal conditions that cause poor absorption of iron, and long-term digestive tract bleeding [25,26].

Low ferritin may also indicate hypothyroidism, vitamin C deficiency or celiac disease [27,28]. Low serum ferritin levels are seen in some patients with restless legs syndrome, not necessarily related to anemia, but perhaps due to low iron stores short of anemia [29]. Falsely low blood ferritin is very uncommon but can result from a hook effect of the measuring tools in extreme cases [30,31].

Animal studies on post-weaning rats and mice have demonstrated that iron deficiency led to deficits in intracellular dopamine concentrations and in the density of dopamine and dopamine transporter receptors, with variable amounts of loss by brain region [32-34]. In addition, ID affects the metabolism of 5-hydroxytryptamine in rat brain and this substance is the precursor in the synthesis serotonin, which is a major neurotransmitter regulating the mood and emotions in the brain [35]. Its deficiency has been reported in relation to mental disorders including depression [36-45].

Significantly reduced extracellular concentrations of noradrenaline in rats were reported by researchers in the caudate putamen, due to reduced iron levels was reported as a result of changes in the expression of noradrenaline transport and noradrenaline receptor proteins in the locus ceruleus and basal ganglia [33,46]. A reduction in serotonin transporter binding was also shown in the nucleus accumbens in iron-deficient rats and the serotonin concentration in the brain was significantly correlated with serum iron level [47,48].

The iron-related enzymes are quite sensitive to depletion of iron throughout the body. In particular, hydroxylases, which are needed for the synthesis of dopamine and serotonin, can malfunction with minor iron deficiency before any manifestation of anemia [49,50]. This is why there are so many symptoms associated with an iron deficiency which may not necessarily be related to anaemia. Well-documented mental consequences of ID include diminished cognitive functions, affective disorders, reduced ability for social adaptation, increased somatic morbidity such as fatigue and pain, and a decreased work capacity [51].

Depression is a mental disorder with a wide range of causes. It is influenced by diverse risk factors, including age, gender, ethnicity, physical health, socioeconomic status, a history of sexual abuse and recent stressful life events. Epidemiological data from various cultures indicate that the prevalence of depression is twice as high in women as in men. In the etiology, physical and psychosocial hypotheses have been proposed to explain the predominance of depression in women [52,53].

Reports suggest that women with physical comorbidity are more prone to developing depression. Women may experience different types of depression and menstrual disorders during their reproductive age, and symptoms may vary during pregnancy, postpartum and menopause [54,55]. A peak in first onsets of depression in women during their childbearing years needing particularly increased iron requirements during menstruation and pregnancy has been reported [56]. There is no evidence, however, that specific medical laboratory diagnoses are independent markers for severity of depression in women. 

Depressive disorders among the female Turkish immigrant population living in Germany was reported to be relatively high, and often mischaracterized as somatic, rather than mental complaints [57,58]. Among others, cultural stigma can play an additional negative role in the appearance and diagnosis of depression, in uprooted Turkish women living in the West [59- 61].

As far as we know, there has been no previous single report on a possible association between iron status and severity of depression. Hence, the present study is undertaken to investigate that I may be involved in the development of depression of premenopausal Turkish women, living as an immigrant in Germany.

Material and Methods

Study design:

A retrospective chart review comparison study was conducted in a period of 12 months, from January to December 2013, to investigate an association between iron status and depression in Turkish women, aged between 18 to 43 years old. This was carried out at the community based internal medicine and psychiatric practices in Germany. Iron parameters in the blood of 180 Turkish women with depression and in 102 Turkish women of matching ages without depression were measured. The measurements for RBC, hemoglobin, serum iron and ferritin of the participants were recorded and results were later statistically analyzed.

The examinations of the patients were carried out by a psychiatrist and were diagnosed according to the International Classification of Diseases-10 (ICD-10, Kapital -V (F) [62]. The severity of the disease was further established by using the Hamilton Depression Rating Scale D (HRS) by means of a structured interview [63]. The HRS’s point system ranges from 0 to 63. Points 25 fulfill the criteria for severe depression. Out of 180 patients, 28 patients met the criteria of minor/mild depression, 74 moderate depression, and 78 severe depression.

Exclusion criteria:

Patients with a family history of blood disorder except for IDA, the patients with increased C- reactive protein (CRP) and increased alanine-transaminase, those who were pregnant, and those suffering from malignancies, diabetes mellitus or mental disorders except depression were excluded from this study. Two control persons with psychosis and three with OCD were also excluded from the study. 

Laboratory assessment: Biochemical measurements of hemoglobin and RBC were made in freshly taken peripheral blood with EDTA, ferritin and free iron in sera without EDTA. Hemoglobin levels and RBC were calculated by HemoCounter (BT-Pro-2401). Serum iron levels were determined by spectrophotometric method (Beckman Coulter AU 2700). Ferritin levels were measured by using immunoassay (Chemiluminometric technology on Advia Centaur XP).

Statistical assessment of the data was made using the ‘Statistical package’ for Social Sciences, on Windows version 15.0 (SPSS, Chicago, IL, USA). Descriptive statistics for each variable were determined.

Median and minimum-maximum values were used for variables by using the normal distribution. Data with normal distribution were compared to Student t-Test (for 2 variables) and ANOVA test (for more than two variables). Comparisons of continuous variables with asymmetric distribution were made by using the Mann-Whitney- U test (for two variables) and Kruskal-Wallis test (for more than two variables). Pearson’s correlation coefficient was used to investigate the relationship between iron variables and HRS. A ‘p’ value less than 0.05 was considered to be significant.

Results

The differences of iron parameters between patient’s group and control’s group were presented in Table 1. The mean age for patients was 28.67±6.55 and for the control group was 29.73±7.12. The mean numbers of the RBC was 4.39 (3.65-5.23) in the patients’ group and 4.49 (2.96-6.15) in the control group.

Table 1. Statistical analysis of variables of patients against controls.

Hemoglobin concentration was 11.10 (8.60-13.70) for the patients and 12.86 (10.20-14.60) for the control group. Serum iron values were 50.92 (11.6-110) for the patients and 69.21 (11.59-146) were for the control group. Ferritin was found to be 39.03 (2.60-99) in patients and 62.61 (9-114) in controls. The differences were found to be significant in all parameters except age.

The Pearson’s test was used to calculate the relationship between variables of iron parameters and depression. No relationship was shown between age and depression (r= 0.016, p>0.05). A significant negative relationship was found between reduced iron parameters and depression (r = - 0.369 p< .001 for the RBC, r = -0.760 p< .001 for the Hb, r =-0.660 p< .001 for the serum iron, r = 0.602 p< .001 for the ferritin respectively).

Table 2. Correlation between HRS and the variables.

Table 3. Statistical analysis of variables within subgroups - patients

The findings were further evaluated to compare the variables within the subgroups of patients (i.e. mild, moderate, severe) by using HRS. Age difference within the subgroups of mild, moderate and severe depression is not significant (p> 0.05). Iron parameters: RBC (106 /mm3 ); 4.82 (2.96-6.15) for mild, 4.29 (3.14-5.70) for moderate, 4.04 (3.20-5.65) for severe depression, (p< 0.001), Hb (g/dl); 12.90 (11.00-13.60) for mild,

Figure 1. The linear regression analysis of RBC, haemoglobin, serum iron and ferritin versus depression score (HRS).

11.25 (9.90-13.70) for moderate, 10.15 (8.60-12.40) for severe depression (p< 0.001), serum Iron (µg/dl); 79.23±16.76 for mild, 55.33±19.55 for moderate, 36.58±14.23 for severe depression (p< 0.001), ferritin (ng/ml) 65.86±18.98 for mild, 42.84±20.09 for moderate and 25.78±16.65 (p< 0.001), (Table 3, Figure 1).

 

 

Discussion

The current study evaluated the relation between serum iron parameters and depression of women in childbearing age. The results demonstrated a significant association between ID and depression. To examine further the issue of ID as a medical condition that might indicate co-morbid depression, we undertook this exploratory study to analyse the relationship between iron- related laboratory parameters and the severity of depression in Turkish female patients; who were diagnosed according to ICD-10.

In agreement with some of the previous studies, our results showed that women with depression tend to have lower iron in their blood than women without depression [64,65]. Reduced iron parameters (i.e. hemoglobin, free serum iron, RBC and ferritin) in sera of patients with depression were also found to associate significantly with severity of depression. The results demonstrated a negative correlation between reduced iron parameters and the intensity of depression in female patients. In practice, haemoglobin concentration is considered to be an indicator for iron deficiency anaemia. However, iron deficiency anaemia is usually assessed by measuring haemoglobin levels but alone this approach lacks both specificity and sensitivity [66].

These findings may remind us a possible causal relationship between iron deficiency and depression in women. We find it difficult, however, to sort out whether ID is a cause of depression itself, or a contributing risk factor in the increased severity of the disease. Nevertheless, this association has to be taken into consideration in the management of this condition. It is, therefore, indispensable to investigate cause of iron deficiency no matter if an anaemia exists. It is important to know that iron deficiency is treatable, and necessary advice over the causes of iron deficiency from relevant medical specialties has to be sought. Iron deficiency, therefore, has to be corrected before the treatment of depression begins [67].

Previous studies suggested that iron may be involved in the molecular level maintaining the cognitive functions [15,17,38]. Failure to identify and treat earlier stages of iron deficiency is concerning given the neurocognitive implications of iron deficiency without anaemia. A sufficient amount of iron is particularly needed for the synthesis of neurotransmitter that plays a significant role in mood disorders [65].

We did not attempt in this study, however, to investigate the entity of anaemia; which would have required further diagnostic laboratory investigation. We chose, therefore, to investigate the most relevant laboratory iron parameters in patients with or without visible iron deficiency anaemia.

Oxidative stress-mediated damage depends on the level of cellular and total body iron status because an excess iron pool produces the most harmful free radicals (hydroxyls) through the Fenton reaction. Ferritins have a central role in the protection against oxidative damage, in which oxidative stress is a major factor in inflammatory, malignant and metabolic diseases [21]. Intracellular ferritin is found in the cytosol of many cells in the body. Ferritin is also found in extracellular fluids such as serum, synovial fluids and milk.

Low serum ferritin is the most sensitive test to detect and manage iron-related disorders, such as iron deficiency anaemia while high levels of ferritin have been associated with malignant disease and tissue damage. Many studies emphasize that iron deficiency may be under recognized by many communities and undertreated [24]. It was also suggested that the ID should be checked, when necessary, iron supplementation, in treating symptoms of depressive patients, should be evaluated further [42,44,45].

Women of reproductive age are at particularly high risk of iron deficiency and its consequences. Premenopausal women usually have low iron status because of iron loss in menstrual blood. Women appear to be particularly vulnerable to comorbid medical conditions, such as migraine, hypothyroidism, celiac disease, Restless-Leg-Syndrome or ID. This is why there are so many symptoms associated with ID which may not necessarily be related to anemia [35,36]; all of which can make depression more difficult to identify and treat successfully. There is a considerable overlap between the two subjects. The question arises as to whether there might be a set of symptoms and perceptions that are shared by ID which might be indicators of depression in addition to the symptoms traditionally attributed to it.

It is widely accepted that many factors including cultures and ethnicity can influence the development of depression in women [68-70]. Our findings may indicate that ID has a strong association in women with Turkish ethnicity. Further, we assume that inadequate treatment may lead to a prolonged duration of depression in patients, with a reduced quality of life as well as other possible side effects. Our results emphasize the need for physicians to be mindful of depressive cases requiring the intervention of iron supplementation, rather than purely anti-depressive treatment [67].

The ability to recognize the depressive symptoms as mentally significant is sometimes difficult, as the same symptoms can be characteristic of non-mental medical conditions. For example, increased fatigue and pain, poor memory, concentration and disturbed cognitive functions can be present in ID [5,38]. For this reason, we would like to draw the attention of physicians on overlapping or similar symptoms in the assessment of the intensity of depression by using HRS.

Our study has several limitations. Firstly, the findings may not be representative of all Turkish women with depression, as the study was conducted in one medical outpatient practice. A further comparative study should be carried out on more Turkish patients, as well as non-Turkish women with depression. It is also essential for a matching study to be carried out in patients living in mainland Turkey.

Secondly, this study is cross-sectional and lacks the capability of showing a firm causal relationship between the symptoms of depression and declined iron status we measured.

A link between mental illness and physical disease is complex. Causal criteria can be used to study this possible link. Strength-Causal inferences are more easily made about strong associations. Weak associations, on the other hand, are much more likely to be the result of unsuspected biases [71]. Further work is required to integrate standard clinical epidemiological concepts.

For certain diagnoses, depression predates the onset of the physical illness: for example, in the case of diabetes. On the other hand, other symptoms such as chronic insomnia, pain and fatigue can, for a while, predate depression. It has been suggested that depression worsens the course of certain pre-existing physical illnesses, such as osteoporosis or coronary artery disease [72,73].

Thirdly, while ferritin in peripheral blood is known to correspond to the total body iron reservoir, it may, however, be found as increased by liver damage or by an inflammatory process as an acute phase protein [74]. We have, therefore, excluded patients with high level ALT and CRP from this study.

The suitability of the age of controls was tested statistically by null hypothesis. The age difference between the control group and the patients has failed to reject null hypothesis. Thus it proves the suitability and reliability for this study

Turkish community represent the biggest ethnic population living in Germany. Distress associated with immigration among the Turkish population was reported to be relatively high. The inability to articulate distress and tendency to somatic presentation is quite common [75]. It was suggested that comorbid physical illness such as ID could be an additional precipitating factor in the development of depression in Turkish women living in Germany [61].

The role of social stigma on reporting depression is often seen in Turkish culture as degrading, as a patient’s resistance to report depression is usually associated with fear of embarrassment or shaming their family. It is important for a doctor to have some appreciation as to how ethnic features including lifestyle, eating habits and nutrition (i.e. ID) will affect the presentation of depression in association with physical health [76,77].

Conclusions

We examined if ID is a risk factor for depression among Turkish women living in Germany. Based on our findings, we hypothesized that ID in Turkish women at least is a risk factor for the severity of depression. Further work is required to establish a causal association. Clinically these findings are potentially useful; as these factors can be measured with relative ease during routine visits, regardless of the chief complaint or illness. Substitution of iron can improve the treatment of depression, by reducing cost, suffering and the prolonging of depressive illness. Thus, we recommend that these factors should be taken into consideration in the diagnosis, treatment and follow-up of the patients with depression. These findings have been presented with the consideration of their clinical implications and with a view to conducting further research.

References

1.Shukla A, Agarwal KN, Chansuria JPN, Taneja V. Effect of Latent Iron Deficiency on 5-Hydroxytryptamine Metabolism in Rat Brain. Journal of Neurochemistry. 2006, 52(3): 730–735.

2. Ye N, Song Z, Zhang A. Dual ligands targeting dopamine D2 and serotonin 5-HT1A receptors as new antipsychotical or anti-parkinsonian agents. Current Medicinal Chemistry. 2014, 21(4): 437–457.

3. Burhans MS, Dailey C, Beard Z, Wiesinger J, Murray-Kolb L et al. Iron deficiency: differential effects on monoamine transporters. Nutr Neurosci. 2005, 8(1): 31–38.

4. Che?chowska M1, Laskowska-Klita T, Leibschang J. Concentration of ferritin, transferrin and iron as a markers of iron deficiency in healthy women in reproductive age. Pol Merkur Lekarski. 2007, 22(127): 25-27.

5. Beard J. Iron deficiency alters brain development and functioning. J Nutr. 2003, 133 (5 Suppl 1): 1468S–1472S.

6. Lozoff B, Georgieff MK. Iron deficiency and brain development. Neurol. 2006, 13(3): 158-165.

7. Thomas C, Thomas L. Biochemical markers and hematologic indices in the diagnosis of functional iron deficiency. Clin Chem. 2002, 48(7): 1066-1076. ic indices in the diagnosis of functional iron deficiency. Clin Chem. 2002, 48(7): 1066-1076.

8. Tan LN, Wei HY, Zhang YD, Lu AL, Li Y et al. Relationship between serum ferritin levels and susceptibility to attention deficit hyperactivity disorder in children: a Meta analysis. Zhongguo Dang Dai Er Ke Za Zhi. 2011, 13(9): 722-724.

9. Lozoff B. Early iron deficiency has brain and behavior effects consistent with dopaminergic dysfunction. J Nutr. 2011, 141(4): 740S–746S.

10. Corwin EJ, Murray-Kolb LE, Beard JL. Low hemoglobin level is a risk factor for postpartum depression. J Nutr. 2003, 133(12): 4139-4142.

11. World Health Organization. Worldwide prevalence of anaemia 1993–2005: WHO global database on anaemia. Geneva: World Health Organization. 2008.

12. World Health Organization. Assessing the iron status of populations: report of a joint world health organization/centers for disease control and prevention technical consultation on the assessment of iron status at the population level. Geneva, Switzerland: Geneva: World Health Organization. 2005.

13. Corwin EJ, Murray-Kolb LE, Beard JL. Low hemoglobin level is a risk factor for postpartum depression. J Nutr. 2003, 133: 4139–4142.

14. Halbreich U. Gonadal hormones, reproductive age, and women with depression. Arch Gen Psychiatry 2000, 57: 1163- 1164.

15. Behr G. A., Moreira J. C. F., Frey B. N. Preclinical and clinical evidence of antioxidant effects of antidepressant agents: implications for the pathophysiology of major depressive disorder. Oxidative Medicine and Cellular Longevity. 2012, 2012:13.

16. ?ura?ková Z. Systems Biology of Free Radicals and Antioxidants. Berlin, Germany: Springer; Free radicals and antioxidants for non-experts. 2014, pp. 3–38.

17. Vaváková M1, ?ura?ková Z1, Trebatická J2. Markers of Oxidative Stress and Neuroprogression in Depression Disorder. Oxid Med Cell Longev. 2015, 2015: 898393. doi: 10.1155/2015/898393. Epub 2015 May 20.

18. Bakunina N, Pariante CM, Zunszain PA. Immune mechanisms linked to depression via oxidative stress and neuroprogression. Immunology. 2015, Jan 10. doi: 10.1111/imm.12443. Epub ahead of print.

19. Thomas Lothar. Labor und Diagnose, Indikation und Bewertung von Laborbefunden für die medizinische Diagnostik, 7. Auflage, TH Books Verlagsgesellschaft Frankfurt. 2008.

20. Shariatpanaahi M.V, Shariatpanaahi ZV, Moshtaaghi M, Shahbaazi SH, Abadi A. The relationship between depression and serum ferritin level. Eur J Clin Nutr. 2007, 61: 532-535.

21. Meyron-Holtz EG1, Moshe-Belizowski S, Cohen LA. A possible role for secreted ferritin in tissue iron distribution. J Neural Transm. 2011, Mar; 118: 337-47. doi: 10.1007/s00702-011- 0582-0. Epub 2011 Feb 6.

22. Catena-Dell’Osso M, Bellantuono C, Consoli G, Baroni S, Rotella F et al. Inflammatory and neurodegenerative pathways in depression: a new avenue for antidepressant development? Current Medicinal Chemistry. 2011, 18: 245–255. doi: 10.2174/092986711794088353.

23. Miller A. H, Maletic V, Raison C. L. Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biological Psychiatry. 2009, 65: 732–741. doi: 10.1016/j.biopsych.2008.11.029. Epub 2009 Jan 15.

24. Yi S, Nanri A, Poudel-Tandukar K, Nonaka D, Matsushita Y et al. Association between serum ferritin concentrations and depressive symptoms in Japanese municipal employees. Psychiatry Res. 2011, 189: 368-372.

25. Monárrez-Espino J, Martínez H, Greiner T. Iron deficiency anemia in reproductive-age Tarahumara women of Northern Mexico. Salud Publica Mex. 2001, 43: 392-401.

26. Murray-Kolb LE. Iron status and neuropsychological consequences in women of reproductive age: what do we know and where are we headed? J Nutrition. 2011, 41: 747-755.

27. Eftekhari MH, Eshraghian MR, Mozaffari-Khosravi H, Saadat N, Shidfar F. Effect of iron repletion and correction of iron deficiency on thyroid function in iron-deficient Iranian adolescent girls. Pak J Biol Sci. 2007, 10: 255–260. doi: 10.3923/ pjbs.2007.255.260.

28. Tran TD, Tran T, Simpson JA, Tran HT, Nguyen TT et al. Infant motor development in rural Vietnam and intrauterine exposures to anaemia, iron deficiency and common mental disorders: a prospective community-based study. BMC Pregnancy Childbirth. 2014, 14: 8. doi: 10.1186/1471-2393-14-8.

29. Schmidt AT, Ladwig EK, Wobken JD, Grove WM, Georgieff MK. Delayed alternation performance in rats following recovery from early iron deficiency. Physiol Behav. 2010, 101: 503– 508. doi:10.1016/j.physbeh.2010.07.015.

30. Albacar G, Sans T, Martín-Santos R, García-Esteve L, Guillamat R et al. An association between plasma ferritin concentrations measured 48 h after delivery and postpartum depression. J Affect Disord. 2011, 131: 136-142. 

31. Stewart RI, Hirani V. Relationship between depressive symptoms, anemia, and iron status in older residents from a national survey population. Psychosom Med. 2012, 74: 208- 213.

32. Beard JL, Unger EL, Bianco LE, Paul T, Rundle SE et al. Early postnatal iron repletion overcomes lasting effects of gestational iron deficiency in rats. J Nutr. 2007, 137: 1176–1182.

33. Erikson KM, Jones BC, Beard JL. Iron deficiency alters dopamine transporter functioning in rat striatum. J Nutr. 2000, 130: 2831–2837.

34. Erikson KM, Jones BC, Hess EJ, Zhang Q, Beard JL. Iron deficiency decreases dopamine D1 and D2 receptors in rat brain. Pharmacol Biochem Behav. 2001, 69: 409–418.

35. Murray-Kolb LE. Iron status and neuropsychological consequences in women of reproductive age: what do we know and where are we headed? J Nutr. 2011, 141:747S-755S. doi: 10.3945/jn.110.130658. Epub 2011 Feb 23.

36. Cortese S, Lecendreux M, Bernardina BD, Mouren MC, Sbarbati A et al. Attention-deficit/hyperactivity disorder, Tourette’s syndrome, and restless legs syndrome: the iron hypothesis. Med Hypotheses. 2008, 70: 1128–1132. doi: 10.1016/j. mehy.2007.10.013.

37. Chen MH, Su TP, Chen YS, Hsu JW, Huang KL et al. Association between psychiatric disorders and iron deficiency anemia among children and adolescents: a nationwide population-based study. BMC Psychiatry. 2013, 13:161.

38. Oner O, Alkar OY, Oner P. Relation of ferritin levels with symptom ratings and cognitive performance in children with attention deficit-hyperactivity disorder. Pediatr Int. 2008, 50: 40-44.

39. Murray-Kolb LE. Iron and brain functions. Curr Opin Clin Nutr Metab Care. 2013, 16:703-707.

40. Lomagno KA, Hu F, Riddell LJ, Booth AO, Szymlek-Gay EA et al. Increasing iron and zinc in pre-menopausal women and its effects on mood and cognition: a systematic review. Nutrients. 2014, 6: 5117-141.

41. Beard JL, Hendricks MK, Perez EM, Murray-Kolb LE, Berg A et al. Maternal iron deficiency anaemia affects postpartum emotions and cognition. J Nutr 2005, 135: 267–272.

42. Veen C, Myint AM, Burgerhout KM, Schwarz MJ, Schütze G et al. Tryptophan pathway alterations in the postpartum period and in acute postpartum psychosis and depression. J Affect Disord. 2015, 189: 298-305. 

43. Stewart R1, Hirani V. Relationship between depressive symptoms, anemia, and iron status in older residents from a national survey population. Psychosom Med. 2012, 74: 208- 213.

44. Murray-Kolb LE1, Beard JL. Iron treatment normalizes cognitive functioning in young women. Am J Clin Nutr. 2007, 85: 778-787.

45. Wojciak RW. Effect of short-term food restriction on iron metabolism, relative well-being and depression symptoms in healthy women. Eat Weight Disord. 2014, 19(3): 321–327.

46. Anderson JG, Fordahl SC, Cooney PT, Weaver TL, Colyer CL et al. Extracellular norepinephrine, norepinephrine receptor and transporter protein and mRNA levels are differentially altered in the developing rat brain due to dietary iron deficiency and manganese exposure. Brain Res. 2009, 1281: 1–14.

47. Erikson KM, Syversen T, Steinnes E, Aschner M. Globus pallidus: a target brain region for divalent metal accumulation associated with dietary iron deficiency. J Nutr Biochem. 2004, 15: 335–341.

48. Pinero DJ, Li NQ, Connor JR, Beard JL. Variations in dietary iron alter brain iron metabolism in developing rats. J Nutr. 2000, 130: 254–263.

49. Hyacinthe C, De Deurwaerdere P, Thiollier T Li Q, Bezard E, Ghorayeb I. Blood withdrawal affects iron store dynamics in primates with consequences on monoaminergic system function. Neuroscience. 2015, 290: 621-635.

50. Unger EL, Bianco LE, Jones BC, Allen RP, Earley CJ. Low brain iron effects and reversibility on striatal dopamine dynamics. Exp Neurol. 2014, 261: 462-468.

51. Auerbach M, Adamson JW. How We Diagnose and Treat Iron Deficiency Anemia. Am J Hematol. 2015 Sep 26. doi: 10.1002/ ajh.24201. [Epub ahead of print]

52. Bromberger JT, Assmann SF, Avis NE, Schocken M, Kravitz HM et al. Persistent mood symptoms in a multiethnic community cohort of pre- and perimenopausal women. Am J Epidemiol. 2003, 158: 347-356.

53. Freeman EW. Associations of depression with the transition to menopause. Menopause. 2010, 17: 823-827.

54. Cekmez Y, Torun F, Göçmen A, ?anl?kan F. A hidden reason for menopausal symptoms in premenopausal aged women: depression. Int J Clin Exp Med. 2015, 8: 6277-81.

55. Coad J, Pedley K. Iron deficiency and iron deficiency anemia in women. Scand J Clin Lab Invest Suppl. 2014, 244:82-89.

56. Khambalia AZ, Collins CE, Roberts CL, Morris JM, Powell KL et al. Iron deficiency in early pregnancy using serum ferritin and soluble transferrin receptor concentrations are associated with pregnancy and birth outcomes. Eur J Clin Nutr. 2015 Sep 16. doi: 10.1038/ejcn.2015.157. [Epub ahead of print]

57. Machleidt W, Calliess IT. Transkulturelle Psychiatrie und Migration – Psychische Erkrankungen aus ethnischer Sicht. Die Psychiatrie. 2005, 2: 77-84.

58. Grube M. Evaluation of a special project for treatment of psychiatrically ill Turkish migrants, Psychiatr Prax. 2001, 28: 81-83.

59. Gül V, Kolb S. Somatisierungsstörungen und psychische Komorbidität, Diagnose und Therapie Optionen am Beispiel türkischer Patienten in Deutschland. Psycho-Neuro. 2008, 34: 213-215.

60. Balkir N, Arens EA, Barnow S. Exploring the relevance of autonomy and relatedness for mental health in healthy and depressed women from two different cultures: when does culture matter? Int J Soc Psychiatry. 2013, 59: 482-92.

61. Gül V, Öner E, Uyar K. Kultur und Ethnizität: Ihre Rolle bei der Entstehung psychischer Störungen am Beispiel der türkischen Gemeinschaft in Deutschland. Psychoneuro. 2008, 34: 97-99.

62. Dilling H, Freyberger H J (Hrsg.). Internationale Klassifikation psychischer Störungen. ICD-10 Kapitel V (F). Klinisch-diagnostische Leitlinien. Verlag Hans Huber. Bern, Göttingen, Toronto, Seattle Taschenbuch. 2004.

63. Williams JBW. A structured interview guide for the Hamilton Depression Rating Scale. Archives of General Psychiatry 1988, 45: 742-747.

64. Khambalia AZ, Collins CE, Roberts CL, Morris JM, Powell KL et al. Iron deficiency in early pregnancy using serum ferritin and soluble transferrin receptor concentrations are associated with pregnancy and birth outcomes. Eur J Clin Nutr. 2015.

65. Coad J, Pedley K. Iron deficiency and iron deficiency anemia in women. Scand J Clin Lab Invest Suppl. 2014, 244: 82-89.

 66. Freeman EW. Associations of depression with the transition to menopause. Menopause. 2010, 17: 823-827.

67. Pasricha SR1, Flecknoe-Brown SC, Allen KJ, Gibson PR, McMahon LP et al. Diagnosis and management of iron deficiency anaemia: a clinical update. Med J Aust. 2010, 193: 525-532.

68. Abdel-Shafi AM, Abdel-Shafi RM. Cultural Influences on the presentation of depression. Open Journal of Psychiatry. 2014, 4: 390-395.

69. Schmeling-Kludas C, Fröschlin R, Boll-Klatt A. Inpatient psychosomatic rehabilitation for Turkish migrants: what can be realized, what are the effects? Rehabilitation (Stuttg). 2003, 42: 363-370.

70. Grube M. Evaluation of a special project for treatment of psychiatrically ill Turkish migrants. Psychiatr Prax. 2001, 28: 81-83.

71. Nicol-Smith L. Causality, menopause, and depression: a critical review of the literature. BMJ. 1996, 313: 1229-1232.

72. Cizza G1, Mistry S, Nguyen VT, Eskandari F, Martinez P et al. Do premenopausal women with major depression have low bone mineral density? A 36-month prospective study. PLoS One. 2012, 7(7).

73. Lichtman JH, J Bigger, Blumenthal JA, Frasure-Smith N, Kaufmann P Get al . Depression and Coronary Heart Disease. 2008, 118: 1768-1775.

74. S. Latha, S. Thirugnanamsambandan, R. T.Arun, K. M. K. Masthan, L. Malathi etal. Serum ferritin level and red blood cell parameters in healthy controls and chronic periodontitis patients. J Pharm Bioallied Sci. 2015, 7(Suppl 1): S184–S189.

75. Schmeling-Kludas C, Fröschlin R, Boll-Klatt A. Inpatient psychosomatic rehabilitation for Turkish migrants: what can be realized, what are the effects? Rehabilitation (Stuttg). 2003, 42: 363-370.

76. Abdel-Shafi AM, Abdel-Shafi RM. Cultural Influences on the presentation of depression. Open Journal of Psychiatry. 2014, 4: 390-395.

77. Bos HM, Boschloo L, Schoevers RA, Sandfort TG. Depression and anxiety in patients with and without same-sex attraction: differences in clinical expression, lifestyle factors, and vulnerability indicators. Brain Behav. 2015, 5(9).